Delaware
GSK stock climbs on Delaware court ruling in Zantac case
GSK (GSK) stock was up 3% Tuesday following a Delaware court ruling on whether certain evidence should be allowed in an ongoing case over the safety of its recalled drug Zantac.
GSK (NYSE:GSK) stock was up 3% in afternoon trading Tuesday in the wake of a ruling by a Delaware court on whether certain evidence should be allowed in an ongoing case over the safety of its recalled drug Zantac.
In a statement released Tuesday afte... [1392 chars]